<DOC>
	<DOCNO>NCT02335827</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy irreversible electroporation ( IRE ) unresectable renal tumor .</brief_summary>
	<brief_title>Irreversible Electroporation ( IRE ) For Unresectable Renal Tumors</brief_title>
	<detailed_description>By enrol patient renal tumor adapt enrolled criterion , study document first time safety short long term efficacy percutaneous intraoperative IRE renal tumor .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>unresectable kidney tumor patient refuse surgical therapy Karnofskyindex &gt; 70 % Age ≥ 18 ≤ 80 year life expectancy ≥ 12 month compliance patient take part study inform consent violation one inclusion criterion estimate glomerular filtration rate ( eGFR ) &lt; 30 mL/min/1.73 m2 QTinterval &gt; 550 m cardiac arrhythmia condition myocardial infarction , make ECGsynchronisation unfeasible active infection severe health interference , make take part study unfeasible pregnancy , lactation period general contraindication anesthesia , endotracheal anesthesia muscle relaxation psychiatric disorder make take part study give informed consent unfeasible haemorrhage , impossible intermission take blood thinner , untreatable thrombophilia thromboplastin time ≤50 % , thrombocytes ≤50 Gpt/L ; partial thromboplastin time &gt; 50 untreated urinary retention severe hepatic dysfunction clinically important renal , hematological , metabolic , neurological , gastrointestinal , hepatic pulmonary disorder dysfunction prevent study participation ( investigator 's assessment ) take part another clinical study renal tumor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>irreversible electroporation</keyword>
	<keyword>renal tumor</keyword>
</DOC>